Field Alert Report Submission: Questions and Answers Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 22, 2021
November 5, 2024
b554a2c6-8278-4f9a-a91c-72bcdd411715
Related Documents
Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2024Center for Drug Evaluation and Research
Q3C(R8) Impurities: Guidance for Residual Solvents Guidance for Industry: Guidance for Industry
Guidance DocumentDecember 10, 2021Center for Drug Evaluation and Research
Bispecific Antibody Development Programs Guidance for Industry
Guidance DocumentMay 24, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox